MiscellaneousCardiovascular effects of vasoactive intestinal peptide in healthy subjects☆
References (33)
- et al.
Possible dual role for vasoactive intestinal peptide as gastrointestinal hormone and neurotransmitter substance
Lancet
(1976) - et al.
Vasoactive intestinal peptide and watery-diarrhea syndrome
Lancet
(1973) VIPoma syndrome
Am J Med
(1987)- et al.
Effect of VIP infusion on water and ion transport in the human jejunum
Gastroenterology
(1980) - et al.
Left ventricular end systolic stress-shortening and stress-length relations in humans
Am J Cardiol
(1982) Effect of somatostatin infusion on VIP-induced transport changes in the human jejunum
Regul Pept
(1984)- et al.
Cardiac dose response relationship for intravenously infused glucagon in normal intact dogs and men
Am Heart J
(1978) - et al.
Physiological assessment of the inotropic vasodilator and afterload reducing effects of milrinone in subjects without cardiac disease
Am J Cardiol
(1985) - et al.
Potent peripheral and splanchnic vasodilator peptide from normal gut
Nature
(1970) - et al.
Polypeptide with broad biological activity: isolation from small intestine
Science
(1976)
Peptides in brain and intestine
Nature
(1976)
Vasoactive intestinal polypeptide (VIP) as a neural peptide
Vasoactive intestinal polypeptide: measurement, distribution and putative neurotransmitter function
Digestion
(1979)
Elevated plasma and tissue levels of vasoactive intestinal polypeptide in the watery-diarrhea syndrome due to pancreatic, bronchogenic and other tumors
N Engl J Med
(1975)
Intestinal secretion induced by vasoactive intestinal polypeptide. A comparison with cholera toxin in the canine jejunum in vivo
J Clin Invest
(1978)
Effect of VIP infusion on water and electrolyte transport in the human intestine
Cited by (0)
- ☆
This study was supported by U.S. Public Health Service grants 1-R01-AM28390-01 and MO1-RR00633.
Copyright © 1987 Published by Elsevier Inc.